Zydus receives tentative approval from USFDA for Levomilnacipran Extended-Release Capsules
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
The company will respond to these observations within the stipulated time period.
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
Subscribe To Our Newsletter & Stay Updated